cresemba
Generic: isavuconazonium sulfate
Labeler: astellas pharma us, inc.Drug Facts
Product Profile
Brand Name
cresemba
Generic Name
isavuconazonium sulfate
Labeler
astellas pharma us, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
isavuconazonium sulfate 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0469-2860
Product ID
0469-2860_7e6e45d4-9266-4451-b6b6-0d054bbcab63
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA207500
Listing Expiration
2026-12-31
Marketing Start
2022-11-22
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04692860
Hyphenated Format
0469-2860
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cresemba (source: ndc)
Generic Name
isavuconazonium sulfate (source: ndc)
Application Number
NDA207500 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/1
Packaging
- 7 BLISTER PACK in 1 CARTON (0469-2860-35) / 5 CAPSULE in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7e6e45d4-9266-4451-b6b6-0d054bbcab63", "openfda": {"unii": ["31Q44514JV"], "rxcui": ["1608327", "1608333", "1608811", "1608815", "2623470", "2623472"], "spl_set_id": ["8f7f73b8-586a-4df0-935f-fecd4696c16c"], "manufacturer_name": ["Astellas Pharma US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 BLISTER PACK in 1 CARTON (0469-2860-35) / 5 CAPSULE in 1 BLISTER PACK", "package_ndc": "0469-2860-35", "marketing_start_date": "20221122"}], "brand_name": "CRESEMBA", "product_id": "0469-2860_7e6e45d4-9266-4451-b6b6-0d054bbcab63", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0469-2860", "generic_name": "isavuconazonium sulfate", "labeler_name": "Astellas Pharma US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CRESEMBA", "active_ingredients": [{"name": "ISAVUCONAZONIUM SULFATE", "strength": "40 mg/1"}], "application_number": "NDA207500", "marketing_category": "NDA", "marketing_start_date": "20221122", "listing_expiration_date": "20261231"}